During the past decade, Clinical Labors of NeuroCode AG conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinical Labors of NeuroCode AG" are "Brain Waves" (1 trials) and "Cognitive Impairment, Mild" (1 trials). Many other conditions were trialed in "Clinical Labors of NeuroCode AG" in a lesser frequency.

Most popular intervention types in "Clinical Labors of NeuroCode AG" are "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Andrographis and Withania" (1 trials), "Conventional White Ginseng" (1 trials) and "HRG80 Hydroponic Red Ginseng" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Labors of NeuroCode AG" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Labors of NeuroCode AG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinical Labors of NeuroCode AG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Labors of NeuroCode AG, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".